Robert Hart, Forbes Staff

Author's posts

Pfizer-BioNTech Says Covid-19 Vaccine Is 95% Effective, Will Seek Emergency Approval Within Days

It comes after Moderna announced interim data from Phase 3 trials showed its vaccine candidate to be 94.5% effective.

Pfizer To Test Covid-19 Vaccine Delivery Program In Four States

The company hopes to preemptively tackle any distribution problems caused by the ultra-cold storage requirements of the vaccine.

Amazon Turns Up The Heat On Brick-And-Mortar Retailers With New Online Pharmacy

The company will deliver prescriptions to U.S. consumers and offer discounts if paying without insurance.

Trump Wants To Go Down In History As The Man Who Ended Covid-19, Claiming Moderna Vaccine Success As His Own

Trump urged historians to remember that the “great discoveries” that will end Covid-19 “all took place on my watch.”

WHO Chief Warns Vaccine Won’t End Covid-19 Pandemic As Moderna, Pfizer Announce Early Successes

The public health leader stressed the need to continue other methods of disease control, like contact tracing, isolating infected patients and testing.

Michigan, Washington Order New Covid-19 Restrictions As U.S. Cases Surge Past 11 Million

The U.S. has reported more than a million new cases in less than a week.

More Infectious And Airborne Covid-19 Mutant Replaced Wuhan Virus To Dominate Worldwide, Research Finds

The researchers believe current vaccine efforts should still be effective on the strain.

Black And Asian People More Likely To Catch Covid-19 In U.S. And U.K., Study Finds

Asian people are also more likely to be admitted to hospital for intensive care with Covid-19, the researchers found.

Fauci Predicts Further Covid-19 Vaccine Success As Moderna Prepares To Submit Early Findings

Fauci described the vaccines by Pfizer and Moderna as a “major step not only for Covid-19 but for the entire field of vaccinology.”

Study Confirms Existence Of ‘Long Covid,’ With 7 In 10 Patients Experiencing Debilitating Symptoms Weeks After Hospital Discharge

40% of patients still had abnormal chest X-rays weeks after discharge, the researchers found, with nearly 10% of these getting worse.